Clinical Trial Update: Myoglobin Removal With CytoSorb in Rhabdomyolysis

View source ↗

Summary

Completed clinical trial evaluating CytoSorb hemoadsorption for myoglobin removal in rhabdomyolysis patients with acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Kidney Injury
• Rhabdomyolysis

Drugs mentioned

• CytoSorb

Snippet

Sponsor: Sisli Hamidiye Etfal Training and Research Hospital | Conditions: Acute Kidney Injury, Rhabdomyolysis | Status: COMPLETED